Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes

Bone

Volumn 50, Issue 2, 2012, Pages 546-552

  Krings, A ^a,c   Rahman, S ^a   Huang, S ^b,d   Lu, Y ^a   Czernik, P J ^a   Lecka Czernik, B ^a,b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adipogenesis; Bone; Brown fat; Marrow fat; White fat

Indexed keywords

ROSIGLITAZONE;

ADIPOGENESIS; ADIPONECTIN GENE; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BROWN ADIPOSE TISSUE; CELL FUNCTION; CELL METABOLISM; CONTROLLED STUDY; DEIODINASE 2 GENE; DIABETES MELLITUS; DRUG SENSITIZATION; FAT CONTENT; FOXC2 GENE; GENE EXPRESSION REGULATION; GENETIC MARKER; INSULIN SENSITIVITY; LEPTIN GENE; MALE; MARKER GENE; NONHUMAN; PGC1 ALPHA GENE; PHENOTYPE; PRDM 16 GENE; TISSUE CHARACTERIZATION; UNCOUPLING PROTEIN 1 GENE; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, BROWN; ADIPOSITY; AGING; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE MARROW; CELL COUNT; DIABETES MELLITUS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; ORGAN SPECIFICITY; PHENOTYPE; THIAZOLIDINEDIONES; TIBIA;

EID: 84855877835     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.06.016     Document Type: Article

References (43)

1. Bianco P., Riminucci M., Gronthos S., Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19:180-192.
2. Botolin S., McCabe L.R. Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 2007, 148:198-205.
3. Bredella M.A., Fazeli P.K., Miller K.K., Misra M., Torriani M., Thomas B.J., et al. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 2009, 94:2129-2136.
4. Calo E., Quintero-Estades J.A., Danielian P.S., Nedelcu S., Berman S.D., Lees J.A. Rb regulates fate choice and lineage commitment in vivo. Nature 2010, 466:1110-1114.
5. Cederberg A., Gronning L.M., Ahren B., Tasken K., Carlsson P., Enerback S. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 2001, 106:563-573.
6. Devlin M.J., Cloutier A.M., Thomas N.A., Panus D.A., Lotinun S., Pinz I., et al. Caloric restriction leads to high marrow adiposity and low bone mass in growing mice. J Bone Miner Res 2010, 25:2078-2088.
7. Duhl D.M., Vrieling H., Miller K.A., Wolff G.L., Barsh G.S. Neomorphic agouti mutations in obese yellow mice. Nat Genet 1994, 8:59-65.
8. Enerback S., Jacobsson A., Simpson E.M., Guerra C., Yamashita H., Harper M.E., et al. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 1997, 387:90-94.
9. Estrach S., Cailleteau L., Franco C.A., Gerhardt H., Stefani C., Lemichez E., et al. Laminin-binding integrins induce Dll4 expression and notch signaling in endothelial cells. Circ Res 2011, [Apr 7, Electronic publication ahead of print].
10. Fernandez-Marcos P.J., Auwerx J. pRb, a switch between bone and brown fat. Dev Cell 2010, 19:360-362.
11. Gesta S., Tseng Y.H., Kahn C.R. Developmental origin of fat: tracking obesity to its source. Cell 2007, 131:242-256.
12. Gimble J.M., Zvonic S., Floyd Z.E., Kassem M., Nuttall M.E. Playing with bone and fat. J Cell Biochem 2006, 98:251-266.
13. Guan H.P., Li Y., Jensen M.V., Newgard C.B., Steppan C.M., Lazar M.A. A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med 2002, 8:1122-1128.
14. Huang S., Kaw M., Harris M.T., Ebraheim N., McInerney M.F., Najjar S.M., et al. Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1. Bone 2010, 46:1138-1145.
15. Kajimura S., Seale P., Spiegelman B.M. Transcriptional control of brown fat development. Cell Metab 2010, 11:257-262.
16. Kim S.H., Cho K.W., Choi H.S., Park S.J., Rhee Y., Jung H.S., et al. The forkhead transcription factor Foxc2 stimulates osteoblast differentiation. Biochem Biophys Res Commun 2009, 386:532-536.
17. Kontani Y., Wang Y., Kimura K., Inokuma K.I., Saito M., Suzuki-Miura T., et al. UCP1 deficiency increases susceptibility to diet-induced obesity with age. Aging Cell 2005, 4:147-155.
18. Kopecky J., Clarke G., Enerback S., Spiegelman B., Kozak L.P. Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J Clin Invest 1995, 96:2914-2923.
19. Krakauer J.C., McKenna M.J., Buderer N.F., Rao D.S., Whitehouse F.W., Parfitt A.M. Bone loss and bone turnover in diabetes. Diabetes 1995, 44:775-782.
20. Lazarenko O.P., Rzonca S.O., Hogue W.R., Swain F.L., Suva L.J., Lecka-Czernik B. Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. Endocrinology 2007, 148:2669-2680.
21. Lecka-Czernik B. Bone loss in diabetes: use of anti-diabetic thiazolidinediones and secondary osteoporosis. Curr Osteoporos Rep 2010, 8:178-184.
22. Liu L.F., Shen W.J., Ueno M., Patel S., Kraemer F.B. Characterization of age-related gene expression profiling in bone marrow and epididymal adipocytes. BMC Genomics 2011, 12. [Epub ahead of print].
23. Moerman E.J., Teng K., Lipschitz D.A., Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004, 3:379-389.
24. Moore S.G., Dawson K.L. Red and yellow marrow in the femur: age-related changes in appearance at MR imaging. Radiology 1990, 175:219-223.
25. Nishikata I., Nakahata S., Saito Y., Kaneda K., Ichihara E., Yamakawa N., et al. Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation. Oncogene 2011, [Apr 25, Electronic publication ahead of print].
26. Olmsted-Davis E., Gannon F.H., Ozen M., Ittmann M.M., Gugala Z., Hipp J.A., et al. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol 2007, 170:620-632.
27. Ouellet V., Routhier-Labadie A., Bellemare W., Lakhal-Chaieb L., Turcotte E., Carpentier A.C., et al. Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans. J Clin Endocrinol Metab 2010, 96:192-199.
28. Pietila M., Palomaki S., Lehtonen S., Ritamo I., Valmu L., Nystedt J., et al. Mitochondrial function and energy metabolism in umbilical cord blood- and bone marrow-derived mesenchymal stem cells. Stem Cells Dev 2011, [May 26, Electronic publication ahead of print].
29. Richard D., Picard F. Brown fat biology and thermogenesis. Front Biosci 2011, 16:1233-1260.
30. Rzonca S.O., Suva L.J., Gaddy D., Montague D.C., Lecka-Czernik B. Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 2004, 145:401-406.
31. Schulz T.J., Huang T.L., Tran T.T., Zhang H., Townsend K.L., Shadrach J.L., et al. Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc Natl Acad Sci U S A 2011, 108:143-148.
32. Seale P., Bjork B., Yang W., Kajimura S., Chin S., Kuang S., et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008, 454:961-967.
33. Seale P., Conroe H.M., Estall J., Kajimura S., Frontini A., Ishibashi J., et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest 2010, 121:96-105.
34. Shen W., Chen J., Punyanitya M., Shapses S., Heshka S., Heymsfield S.B. MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women. Osteoporos Int 2007, 18:641-647.
35. Soyal S., Krempler F., Oberkofler H., Patsch W. PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia 2006, 49:1477-1488.
36. Syed F.A., Hoey K.A. Integrative physiology of the aging bone: insights from animal and cellular models. Ann N Y Acad Sci 2010, 1211:95-106.
37. Syed F.A., Oursler M.J., Hefferanm T.E., Peterson J.M., Riggs B.L., Khosla S. Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int 2008, 19:1323-1330.
38. Tontonoz P., Spiegelman B.M. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008, 77:289-312.
39. Vernochet C., Peres S.B., Davis K.E., McDonald M.E., Qiang L., Wang H., et al. C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists. Mol Cell Biol 2009, 29:4714-4728.
40. Virtanen K.A., Lidell M.E., Orava J., Heglind M., Westergren R., Niemi T., et al. Functional brown adipose tissue in healthy adults. N Engl J Med 2009, 360:1518-1525.
41. Wolff G.L., Roberts D.W., Mountjoy K.G. Physiological consequences of ectopic agouti gene expression: the yellow obese mouse syndrome. Physiol Genomics 1999, 1:151-163.
42. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 2004, 351:1106-1118.
43. Lecka-Czernik B. Marrow fat metabolism is linked to the systemic energy metabolism. Bone this issue. doi:. http://10.1016/j.bone.2011.06.032.